Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
87.1 ILa | +5.45% | -0.68% | +37.82% |
03-19 | Dna Group (T.R.) Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Dna Group (T.R.) Ltd Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Sales 2022 | 0.56 209.62 0.77 | Sales 2023 | 0.31 114.54 0.42 | Capitalization | 77.84M 29.14B 107M |
---|---|---|---|---|---|
Net income 2022 | -23M -8.61B -31.54M | Net income 2023 | -1M -374M -1.37M | EV / Sales 2022 | 38,063,516 x |
Net cash position 2022 | 65.73M 24.6B 90.14M | Net cash position 2023 | 66.7M 24.97B 91.47M | EV / Sales 2023 | 36,410,820 x |
P/E ratio 2022 |
-3.6
x | P/E ratio 2023 |
-63.2
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 45.14% |
1 day | +5.45% | ||
1 week | -0.68% | ||
Current month | +9.84% | ||
1 month | +9.84% | ||
3 months | +26.97% | ||
6 months | +20.30% | ||
Current year | +37.82% |
Managers | Title | Age | Since |
---|---|---|---|
Ori Altschuler
CEO | Chief Executive Officer | 41 | 22-01-17 |
Klein Tony Hanan
DFI | Director of Finance/CFO | 44 | 15-11-14 |
Daniel Spira
AUD | Comptroller/Controller/Auditor | 69 | 10-04-26 |
Members of the board | Title | Age | Since |
---|---|---|---|
Orit Stav
BRD | Director/Board Member | 53 | 22-10-19 |
Erez Navon
CHM | Chairman | 50 | 21-02-23 |
Ronen Midbari
BRD | Director/Board Member | 49 | 19-03-18 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-02 | 87.1 | +5.45% | 7 725 |
24-05-01 | 82.6 | +1.60% | 98,711 |
24-04-30 | 81.3 | -5.24% | 338,988 |
24-04-25 | 85.8 | -2.17% | 128,607 |
Delayed Quote TEL AVIV STOCK EXCHANGE, May 02, 2024 at 03:26 am
More quotes1st Jan change | Capi. | |
---|---|---|
+37.82% | 27.09M | |
+0.67% | 42.4B | |
+46.85% | 40.04B | |
-6.20% | 28.31B | |
+6.55% | 24.94B | |
-21.66% | 18.96B | |
+29.96% | 12.3B | |
-1.57% | 11.95B | |
+16.03% | 11.32B | |
-4.80% | 11.55B |
- Stock Market
- Equities
- DNA Stock